Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track

T-cells and cancer cells

The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration. . . . → Read More: Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track

Trial Okayed for Gene-Edited Stem Cell Lupus Treatment

Natural killer cell

A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus. . . . → Read More: Trial Okayed for Gene-Edited Stem Cell Lupus Treatment

Study to Provide Real World Data for A.I. Seizure Forecasts

Embrace2 smart watch

A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures. . . . → Read More: Study to Provide Real World Data for A.I. Seizure Forecasts

Organ Chip Devices to Model for Radiation Sickness

Organ on a chip

The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness. . . . → Read More: Organ Chip Devices to Model for Radiation Sickness

FDA Funds Study of Real World Data for Biosimilars

Medical gear

A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs. . . . → Read More: FDA Funds Study of Real World Data for Biosimilars

FDA Clears Genetic Cancer Risk Detection Test

DNA illustration

The Food and Drug Administration authorized marketing of a genetic test for detecting hundreds of gene variants associated with a higher risk of developing certain cancers. . . . → Read More: FDA Clears Genetic Cancer Risk Detection Test

FDA Clears Biotech Seasonal Flu Treatment Trial

3-D print of influenza virus

A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains. . . . → Read More: FDA Clears Biotech Seasonal Flu Treatment Trial

Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Healthy neuron illustration

A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Autoimmune Neuro Disease Start-Up Raises $58M

Mental health graphic

A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M

FDA Issues Guidance for Opioid Therapy Device Trials

Ambulance at night

The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials